Publication Date:
2012-07-19
Description:
Background: Germline mutations of BRCA1/2 are associated with hereditary breast and ovarian cancer.Recent data suggests excess mortality in mutation carriers beyond that conferred byneoplasia, and recent in vivo and in vitro studies suggest a modulatory role for BRCAproteins in endothelial and cardiomyocyte function. We therefore tested the association ofBRCA2 variants with clinical cardiovascular disease (CVD). Methods: Using data from 1,170 individuals included in two multi-ethnic population-based studies(SHARE and SHARE-AP), the association between BRCA2 variants and CVD wasevaluated. 15 SNPs in BRCA2 with minor allele frequencies (MAF) 〉 0.01 had beenpreviously genotyped using the cardiovascular gene-centric 50 k SNP array. 115 individuals(9.8%) reported a CVD event, defined as myocardial infarction (MI), angina, silent MI,stroke, and angioplasty or coronary artery bypass surgery. Analyses were adjusted for ageand sex. The SNPs rs11571836 and rs1799943 were subsequently genotyped using theMassARRAY platform in 1,045 cases of incident MI and 1,135 controls from the SouthAsian subset of an international case-control study of acute MI (INTERHEART), andrs11571836 was imputed in 4,686 cases and 4500 controls from the Pakistan Risk ofMyocardial Infarction Study (PROMIS). Results: Two BRCA2 SNPs, rs11571836 and rs1799943, both located in untranslated regions, wereassociated with lower risk of CVD (OR 0.47 p = 0.01 and OR 0.56 p = 0.03 respectively) inthe SHARE studies. Analysis by specific ethnicities demonstrated an association with CVDfor both SNPs in Aboriginal People, and for rs11571836 only in South Asians. No associationwas observed in the European and Chinese subgroups. A non-significant trend towards anassociation between rs11571836 and lower risk of MI was observed in South Asians fromINTERHEART [OR = 0.87 (95% CI: 0.75-1.01) p = 0.068], but was not evident in PROMIS[OR = 0.96 (95% CI: 0.90-1.03) p = 0.230]. Meta-analysis of both case-control studiesresulted in a combined OR of 0.94 (95% CI: 0.89-1.004, p = 0.06). Conclusions: Although there was an association between two SNPs in BRCA2 and CVD in a multi-ethnicpopulation, these results were not replicated in two South Asian case-control studies ofincident MI. Future studies exploring the association between BRCA variants andcardiovascular disorders are needed to clarify the role, if any, for BRCA variants in CVDpathogenesis.
Electronic ISSN:
1471-2350
Topics:
Biology
,
Medicine
Permalink